Chemotherapy-induced hair loss

Handbook of Hair in Health and Disease

Volumn , Issue , 2012, Pages 403-416

  van den Hurk, Corina J G ^a   Breed, Wim P M ^a   Mols, Floortje ^a,b  

^a Eindhoven Cancer Registry   (Netherlands)

^b TILBURG UNIVERSITY   (Netherlands)

Author keywords

Alopecia; CIA; Prevention; Scalp cooling; Well being

Indexed keywords

EID: 84859743060     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3920/978-90-8686-728-8_20     Document Type: Chapter

References (46)

1. Ariin, Z.A., Friedland, M.L. and Atamer, M.A., 1984. Selective alopecia with mitoxantrone. New England Journal of Medicine 310, 1464.
2. Batchelor, D., 2001. Hair and cancer chemotherapy: consequences and nursing care-a literature study. European Journal of Cancer Care (Engl) 10, 147-163.
3. Benjamin, B., Ziginskas, D., Harman, J. and Meakin, T., 2002. Pulsed electrostatic fields (ETG) to reduce hair loss in women undergoing chemotherapy for breast carcinoma: a pilot study. Psychooncology 11, 244-248.
4. Bleiker, T.O., Nicolaou, N., Traulsen, J. and Hutchinson, P.E., 2005. "Atrophic telogen effluvium" from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. British Journal of Dermatology 153, 103-112.
5. Boehmke, M.M. and Dickerson, S.S., 2005. Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nursing 28, 382-389.
6. Botchkarev, V.A., Komarova, E.A., Siebenhaar, F., Botchkareva, N.V, Komarov, P.G., Maurer, M., Gilchrest, B.A. and Gudkov, A.V., 2000. p53 is essential for chemotherapy-induced hair loss. Cancer Research 60, 5002-5006.
7. Breed, W.P., Van den Hurk, C.J.G. and Peerbooms, M., 2011. Presentation, impact and prevention of chemotherapy- induced hair loss; scalp cooling potentials and limitations. Expert Review Dermatology 6, 109-125.
8. Carpenter, J.S. and Brockopp, D.Y., 1994. Evaluation of self-esteem of women with cancer receiving chemotherapy. Oncology Nursing Forum 21, 751-757.
9. Cohen, B., 2008. The cross-section trichometer: a new device for measuring hair quantity, hair loss, and hair growth. Dermatological Surgery 34, 900-911.
10. Cotsarelis, G. and Millar, S.E., 2001. Towards a molecular understanding of hair loss and its treatment. Trends in Molecular Medicine 7, 293-301.
11. Davis, S.T., Benson, B.G., Bramson, H.N., Chapman, D.E., Dickerson, S.H., Dold, K.M., Eberwein, D.J., Edelstein, M., Frye, S.V., Gampe Jr, R.T., Griffin, R.J., Harris, P.A., Hassell, A.M., Holmes, W.D., Hunter, R.N., Knick, V.B., Lackey, K., Lovejoy, B., Luzzio, M.J., Murray, D., Parker, P., Rocque, W.J., Shewchuk, L., Veal, J.M., Walker, D.H. and Kuyper, L.F., 2001. Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors. Science 291, 134-137.
12. Fobair, P., Stewart, S.L., Chang, S., D'Onofrio, C., Banks, PJ. and Bloom, J.R., 2006. Body image and sexual problems in young women with breast cancer. Psychooncology 15, 579-594.
13. Freedman, T.G., 1994. Social and cultural dimensions of hair loss in women treated for breast cancer. Cancer Nursing 17, 334-341.
14. Frith, H., Harcourt, D. and Fussell, A., 2007. Anticipating an altered appearance: women undergoing chemotherapy treatment for breast cancer. European Journal of Oncology Nursing 11, 385-391.
15. Grevelman, E.G. and Breed, W.P., 2005. Prevention of chemotherapy-induced hair loss by scalp cooling. Annals of Oncology 16, 352-358.
16. Heeringa, M. and Fischer-Steenvoorden, M.G.J., 1999. [article in Dutch] 30 jaar grijze vrouw krijgt eigen haarkleur terug. Verandering van haarkleur door geneesmiddelen. Pharmaceutisch Weekblad 139, 670-675.
17. Hendriks, M.A.E., Geerts, P.A.F., Dercksen, P.A.F., Van den Hurk, C.J.G. and Breed, W.P.M., 2010. The usefulness of Cohen's cross-section trichometer for measuring hair quantity. Dermatological Surgery (in press).
18. Hilton, S., Hunt, K., Emslie, C., Salinas, M. and Ziebland, S., 2008. Have men been overlooked? A comparison of young men and women's experiences of chemotherapy-induced alopecia. Psychooncology 17, 577-583.
19. Husson, O., Mols, F. and Van de Poll-Franse, L.V., 2011. The relation between information provision and health- related quality of life, anxiety and depression among cancer survivors: a systematic review. Annals of Oncology 22: 761-772.
20. Imanishi, H., Tsuruta, D., Tateishi, C., Sugawara, K., Paus, R., Tsuji, T., Ishii, M., Ikeda, K., Kunimoto, H., Nakajima, K., Jones, J.C. and Kobayashi, H., 2010. Laminin-511, inducer of hair growth, is down-regulated and its suppressor in hair growth, laminin-332 up-regulated in chemotherapy-induced alopecia. Journal of Dermatological Science 58, 43-54.
21. Karakunnel, J.J. and Berger, A.M., 2008. Hair loss. In: DeVita, V., Lawrence, W. and Rosenberg, S. (eds.) Cancer: Principles & Practice of Oncology, pp. 2688-2691.
22. Kligman, A.M., 1961. Pathologic dynamics of human hair loss. I. Telogen effuvium. Archives of Dermatology 83, 175-198.
23. Land, S.R., Kopec, J.A., Yothers, G., Anderson, S., Day, R., Tang, G., Ganz, P.A., Fisher, B. and Wolmark, N., 2004. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23. Breast Cancer Research and Treatment 86, 153-164.
24. Lovejoy, N.C., 1979. Preventing hair loss during adriamycin therapy. Cancer Nursing 2, 117-121.
25. Macduff, C., Mackenzie, T., Hutcheon, A., Melville, L. and Archibald, H., 2003. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. European Journal of Cancer Care (Engl) 12, 154-161.
26. Massey, C.S., 2004. A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy. European Journal of Oncology Nursing 8, 121-130.
27. McGarvey, E.L., Leon-Verdin, M., Baum, L.D., Bloomfield, K., Brenin, D.R., Koopman, C., Acton, S., Clark, B. and Parker jr., B.E., 2010. An evaluation of a computer-imaging program to prepare women for chemotherapy- related alopecia. Psychooncology 19, 756-766.
28. Mols, F., Van den Hurk, C.J., Vingerhoets, A.J. and Breed, W.P., 2009. Scalp cooling to prevent chemotherapy- induced hair loss: practical and clinical considerations. Supportive Care in Cancer 17, 181-189.
29. Mulders, M., Vingerhoets, A. and Breed, W., 2008. The impact of cancer and chemotherapy: Perceptual similarities and differences between cancer patients, nurses and physicians. European Journal of Oncology Nursing 12, 97-102.
30. Munstedt, K., Manthey, N., Sachsse, S. and Vahrson, H., 1997. Changes in self-concept and body image during alopecia induced cancer chemotherapy. Supportive Care in Cancer 5, 139-143.
31. Okun, E., Saida, H., Albeck, M., Sredni, B. and Avtalion, R.R., 2006. Upregulation of carp GDNF mRNA by the immunomodulator AS101. Developmental and Comparative Immunology 30, 441-446.
32. Pickard-Holley, S., 1995. The symptom experience of alopecia. Seminars in Oncology Nursing 11, 235-238.
33. Read, W, 2010. Baldness reversed by chemotherapy. Journal of the American Academy of Dermatology 63, 727-728.
34. Rebora, A., 1997. Telogen effluvium. Dermatology 195, 209-212.
35. Rodriguez, R., Machiavelli, M., Leone, B., Romero, A., Cuevas, M.A., Langhi, M., Romero Acuna, L., Romero Acuna, J., Amato, S., Barbieri, M., Vallejo, C., Rabinovich, M., Perez, J., Sabatini, C., Ortiz, E., Salvadori, M. and Lacava, J., 1994. Minoxidil (Mx) as a prophylaxis of doxorubicin--induced alopecia. Annals of Oncology 5, 769-770.
36. Rosman, S., 2004. Cancer and stigma: experience of patients with chemotherapy-induced alopecia. Patient Education Counselling 52, 333-339.
37. Sharov, A.A., Siebenhaar, F., Sharova, T.Y., Botchkareva, N.V., Gilchrest, B.A. and Botchkarev, V A., 2004. Fas signaling is involved in the control of hair follicle response to chemotherapy. Cancer Research 64, 6266-6270.
38. Sredni, B., Gal, R., Cohen, I.J., Dazard, J.E., Givol, D., Gafter, U., Motro, B., Eliyahu, S., Albeck, M., Lander, H.M. and Kalechman, Y., 2004. Hair growth induction by the Tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras-dependent up-regulation of KGF expression. Faseb Journal 18, 400-402.
39. Sredni, B., Xu, R.H., Albeck, M., Gafter, U., Gal, R., Shani, A., Tichler, T., Shapira, J., Bruderman, I., Catane, R., Kaufman, B., Whisnant, J.K., Mettinger, K.L. and Kalechman, Y., 1996. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models. International Journal of Cancer 65, 97-103.
40. Tallon, B., Blanchard, E. and Goldberg, L.J., 2009. Permanent chemotherapy-induced alopecia: case report and review of the literature. Journal of the American Academy of Dermatology 63, 333-336.
41. Tierney, A., Taylor, J., Closs, S.J., Chetty, U., Rodger, A. and Leonard, R.C.F., 1990. Hair loss due to cytotoxic chemotherapy - a prospective descriptive study. British Journal of Cancer 62, 527-528.
42. Trueb, R.M., 2009. Chemotherapy-induced alopecia. Seminars in Cutaneous Medicine and Surgery 28, 11-14.
43. Van den Hurk, C.J., Mols, F., Vingerhoets, A.J. and Breed, W.P., 2010. Impact of alopecia and scalp cooling on the well-being of breast cancer patients. Psychooncology 19, 701-709.
44. Van den Hurk, C.J.G., Coebergh, J.W.W., Breed, W.P.M., Van de Poll-Franse, L.V. and Nortier, J.W.R., 2009. Shorter post-infusion cooling time of scalp cooling in the prevention of docetaxel-induced hair loss. European Journal of Cancer, suppl 7, 181.
45. Wang, J., Lu, Z. and Au, J.L., 2006. Protection against chemotherapy-induced alopecia. Pharmacological Research 23, 2505-2514.
46. Williams, J., Wood, C. and Cunningham-Warburton, P., 1999. A narrative study of chemotherapy-induced alopecia. Oncology Nursing Forum 26, 1463-1468.